Differential Role of CCR2 in Islet and Heart Allograft Rejection: Tissue Specificity of Chemokine/Chemokine Receptor Function In Vivo

Journal of Immunology

Volumn 172, Issue 2, 2004, Pages 767-775

  Abdi, Reza ^a,b   Means, Terry K ^c   Ito, Toshiro ^d   Smith, Rex Neal ^d   Najafian, Nader ^a,b   Jurewicz, Mollie ^a,b   Tchipachvili, Vaja ^e   Charo, Israel ^f   Auchincloss Jr , Hugh ^d   Sayegh, Mohamed H ^a,b   Luster, Andrew D ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e JOSLIN DIABETES CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; G PROTEIN COUPLED RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ALLOGRAFT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; ENZYME LINKED IMMUNOSPOT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; LEUKOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE ACTIVATION; TARGET CELL; TISSUE SPECIFICITY;

EID: 9144253897     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.2.767     Document Type: Article

References (30)

1. Nelson, P. J., and A. M. Krensky. 2001. Chemokines, chemokine receptors, and allograft rejection. Immunity 14:377.
2. Fairchild, R. L., A. M. VanBuskirk, T. Kondo, M. E. Wakely, and C. G. Orosz. 1997. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation 63:1807.
3. Kapoor, A., K. Morita, T. M. Engeman, E. M. Vapnek, M. Hobart, A. C. Novick, and R. L. Fairchild. 2000. Intragraft expression of chemokine gene occurs early during acute rejection of allogeneic cardiac grafts. Transplant. Proc. 32:793.
4. Miura, M., K. Morita, H. Kobayashi, T. A. Hamilton, M. D. Burdick, R. M. Strieter, and R. L. Fairchild. 2001. Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J. Immunol. 167:3494.
5. Hancock, W. W., W. Gao, V. Csizmadia, K. L. Faia, N. Shemmeri, and A. D. Luster. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193:975.
6. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192:1515.
7. Robinson, L. A., C. Nataraj, D. W. Thomas, D. N. Howell, R. Griffiths, V. Bautch, D. D. Patel, L. Feng, and T. M. Coffman. 2000. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J. Immunol. 165:6067.
8. Gao, W., P. S. Topham, J. A. King, S. T. Smiley, V. Csizmadia, B. Lu, C. J. Gerard, and W. W. Hancock. 2000. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J. Clin. Invest. 105:35.
9. Schroppel, B., M. Fischereder, R. Ashkar, M. Lin, B. K. Kramer, B. Mardera, T. Schiano, and B. Murphy. 2002. The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation. Am. J. Transplant. 2:640.
10. Abdi, R., T. B. Tran, A. Sahagun-Ruiz, P. M. Murphy, B. M. Brenner, E. L. Milford, and D. H. McDermott. 2002. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J. Am. Soc. Nephrol. 13:754.
11. Abdi, R., R. N. Smith, L. Makhlouf, N. Najafian, A. D. Luster, H. Auchincloss, Jr., and M. H. Sayegh. 2002. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 51:2489.
12. Luster, A. D. 2002. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14:129.
13. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894.
14. Izikson, L., R. S. Klein, I. F. Charo, H. L. Weiner, and A. D. Luster. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192:1075.
15. Peters, W., H. M. Scott. H. F. Chambers, J. L. Flynn, I. F. Charo. and J. D. Ernst. 2001. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 98:7958.
16. Traynor, T. R., A. C. Herring, M. E. Dorf, W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2002. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J. Immunol. 168:4659.
17. Boring, L., J. Gosling, S. W. Chensue, S. L. Kunkel, R. V. Farese, Jr., H. E. Broxmeyer, and I. F. Charo. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552.
18. Makhlouf, L., K. Kishimoto, R. N. Smith, R. Abdi, M. Koulmanda, H. J. Winn, H. Auchincloss, Jr., and M. H. Sayegh. 2002. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Diabetes 51:3202.
19. Kishimoto, K., V. M. Dong, S. Issazadeh, E. V. Fedoseyeva, A. M. Waaga, A. Yamada, M. Sho, G. Benichou, H. Auchincloss, Jr., M. J. Grusby, et al. 2000. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J. Clin. Invest. 106:63.
20. Means, T. K., F. Hayashi, K. D. Smith, A. Aderem, and A. D. Luster. 2003. The TLR5-stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J. Immunol. 170:5166.
21. + T cells by skin grafts via direct antigen presentation. J. Immunol. 169:1270.
22. Harada, H., A. D. Salama, M. Sho, A. Izawa, S. E. Sandner, T. Ito, H. Akiba, H. Yagita, A. H. Sharpe, G. J. Freeman, and M. H. Sayegh. 2003. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J. Clin. Invest. 112:234.
23. McKallip, R. J., Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti. 2002. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int. Immunol. 14:1015.
24. + T cell-mediated rejection of pancreatic islet allografts. J. Immunol. 165:247.
25. + T cell effectors that cause myocarditis. J. Clin. Invest. 111:671.
26. Shehadeh, N. N., F. LaRosa, and K. J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291.
27. Yamada, A., K. Kishimoto, V. M. Dong, M. Sho, A. D. Salama, N. G. Anosova, G. Benichou, D. A. Mandelbrot, A. H. Sharpe, L. A. Turka, et al. 2001. CD28-independent costimulation of T cells in alloimmune responses. J. Immunol. 167:140.
28. + cells are essential for allorejection. J. Exp. Med. 184:2013.
29. Makhlouf, L., A. Yamada, T. Ito, R. Abdi, M. J. Ansari, C. Q. Khuong, H. J. Winn, H. Auchincloss, Jr., and M. H. Sayegh. 2003. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. J. Am. Soc. Nephrol. 14:2168.
30. + T lymphocyte deficient mice. Transplantation 55:718.